Cytokine storms: CAR T-cell hyperinflammatory response distinct from cytokine release syndrome?

Cytokine release syndrome (CRS) is a relatively well-described toxicity of CAR T-cell therapy. However, their may be delayed manifestations of CRS, such as disseminated intravascular coagulation (DIC)... Author: VJHemOnc Added: 01/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts